Thomas McCourt
Chief Executive Officer chez IRONWOOD PHARMACEUTICALS, INC.
Fortune : 11 M $ au 31/03/2024
Postes actifs de Thomas McCourt
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| IRONWOOD PHARMACEUTICALS, INC. | Director/Board Member | 04/06/2021 | - |
| Chief Executive Officer | 12/03/2021 | - | |
| President | 01/04/2019 | - | |
| Sales & Marketing | 01/01/2009 | 01/04/2019 | |
| PLIANT THERAPEUTICS, INC. | Director/Board Member | 06/03/2023 | - |
| Independent Dir/Board Member | 06/03/2023 | - | |
| American Society for Gastrointestinal Endoscopy | Director/Board Member | 01/05/2009 | - |
Historique de carrière de Thomas McCourt
Anciens postes connus de Thomas McCourt
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ACCELERON PHARMA INC. | Director/Board Member | 25/07/2016 | 19/11/2021 |
| Independent Dir/Board Member | 25/07/2016 | 19/11/2021 | |
| NOVARTIS AG | Sales & Marketing | 01/01/2001 | 01/01/2008 |
Astra Merck, Inc.
 Astra Merck, Inc. Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, Astra Merck, Inc. is a private company that sells pharmaceutical products. The company is based in Orlando, FL. The company was founded by Myrtle S. Potter, Thomas A. McCourt. Astra Merck was acquired by Astra AB from Merck & Co., Inc. on July 12, 1998 for $4,400 million. | Founder | 01/04/1992 | 01/06/1999 |
| Corporate Officer/Principal | 01/04/1992 | 01/06/1999 |
Formation de Thomas McCourt
| University of Wisconsin | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 7 |
| Suisse | 2 |
Opérationnelle
| Director/Board Member | 4 |
| Sales & Marketing | 2 |
| Independent Dir/Board Member | 2 |
Sectorielle
| Health Technology | 6 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| IRONWOOD PHARMACEUTICALS, INC. | Health Technology |
| NOVARTIS AG | Health Technology |
| PLIANT THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Acceleron Pharma, Inc.
 Acceleron Pharma, Inc. BiotechnologyHealth Technology Acceleron Pharma, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of therapeutics to treat serious and rare diseases. Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension. The company was founded by John L. Knopf and Thomas P. Maniatis in June 2003 and is headquartered in Cambridge, MA. | Health Technology |
Astra Merck, Inc.
Astra Merck, Inc. Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, Astra Merck, Inc. is a private company that sells pharmaceutical products. The company is based in Orlando, FL. The company was founded by Myrtle S. Potter, Thomas A. McCourt. Astra Merck was acquired by Astra AB from Merck & Co., Inc. on July 12, 1998 for $4,400 million. | Health Technology |
| American Society for Gastrointestinal Endoscopy |
- Bourse
- Insiders
- Thomas McCourt
- Expérience
